The effects of drug therapy on radiographic progression of rheumatoid arthritis. results of a 36‐week randomized trial comparing methotrexate and auranofin

Arthritis & Rheumatism

Volumn 36, Issue 5, 1993, Pages 613-619

  Weinblatt, Michael E ^a,b   Polisson, Richard ^a,b   Blotner, Steven D ^a,b   Leland Sosman, J ^a,b   Aliabadi, Piran ^a,b   Baker, Nancy ^a,b   Weissman, Barbara N ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AURANOFIN; METHOTREXATE;

ADULT; ARTICLE; BONE EROSION; BONE RADIOGRAPHY; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSSIFICATION; PRIORITY JOURNAL; RADIODIAGNOSIS; RHEUMATOID ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; AURANOFIN; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; FEMALE; HUMAN; MALE; METHOTREXATE; MIDDLE AGE; SEVERITY OF ILLNESS INDEX; SUPPORT, NON-U.S. GOV'T;

EID: 0027232711     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780360507     Document Type: Article

References (28)

1. Does drug therapy slow radiographic deterioration in rheumatoid arthritis?
2. Radiographic evidence of disease progression in methotrexate treated and non methotrexate disease modifying antirheumatic drug tested rheumatoid arthritis patients: a meta‐analysis
3. Efficacy of low‐dose methotrexate in rheumatoid arthritis
4. Comparison of low‐dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial
5. Weekly pulse methotrexate in rheumatoid arthritis: clinical and immunologic effects in a randomized, double‐blind study
6. A randomized controlled trial of parenteral methotrexate compared with sodium aurothiomalate (Myochrysine) in the treatment of rheumatoid arthritis
7. A double blind randomized parallel trial of intramuscular methotrexate and gold sodium thiomalate in early erosive rheumatoid arthritis
8. Methotrexate versus azathioprine in the treatment of rheumatoid arthritis: a forty‐eight‐week randomized, double‐blind trial
9. Long‐term prospective study of methotrexate in the treatment of rheumatoid arthritis: 84‐month update
10. Long‐term prospective study of the use of methotrexate in rheumatoid arthritis: update after a mean of 90 months
11. Low‐dose methotrexate compared with auranofin in adult rheumatoid arthritis: a thirty‐six‐week, double‐blind trial
12. Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis: a controlled clinical trial
13. Long‐term prospective trial of low‐dose methotrexate in rheumatoid arthritis
14. The safety and efficacy of the use of methotrexate in long‐term therapy for rheumatoid arthritis
15. A long‐term prospective study of the use of methotrexate in rheumatoid arthritis: update after a mean of fifty‐three months
16. Pulse methotrexate therapy in rheumatoid arthritis: a controlled prospective roentgenographic study
17. Prospective long term follow‐up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression
18. Methotrexate treatment of rheumatoid arthritis: effects on radiological progression
19. Radiologic progression during intramuscular methotrexate treatment of rheumatoid arthritis
20. Retardation of radiologic progression in rheumatoid arthritis with methotrexate therapy: a controlled study
21. Low‐dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis: a twenty‐four‐week controlled clinical trial
22. Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis: a randomized, double‐blind study
23. Radiological assessment of disease progression in rheumatoid arthritis patients from the randomized clinical trial of methotrexate, oral gold or combination (abstract)
24. Articular indices of joint inflammation in rheumatoid arthritis: correlation with the acute‐phase response
25. Rheumatoid arthritis: relation of serum C‐reactive protein and erythrocyte sedimentation rates to radiographic changes
26. Assessment of radiologic progression in rheumatoid arthritis: a randomized, controlled trial
27. Reproducibility of multiple‐observer scoring of radiologic abnormalities in the hands and wrists of patients with rheumatoid arthritis
28. Radiologic assessment as an outcome measure in rheumatoid arthritis